Medical marijuana stocks in Canada have tripled, on average, in value since August.
The tell is in the tape, as they say. On Tuesday, the TSX Venture’s highest volume traders by dollar amount were all Marijuana for Medical Purposes Regulations (MMPR)-licensed producers.
Aurora Cannabis Inc., (
CVE:ACB), Aphria Inc. (
CVE:APH), OrganiGram Holdings Inc. (
CVE:OGI), and Maple Leaf Green World Inc. (
CVE:MGW) were ranked one through four as of market close. On the TSX main board, it was Canopy Growth Corp (
TSE:CGC) delivering one of the best performances of the session, rising by 4.73 per cent to $5.53 on volume of 3.3 million shares worth $18.4 million.
A total of 14 million shares worth $48 million traded hands which is highly unusual when there is no sector-specific news to drive that kind of interest.
According to John Fowler, CEO of Supreme Pharmaceuticals Inc. (
CNSX:SL), whose share price has tripled in the last three months, investors are positioning ahead of anticipated federal government rules permitting the consumption of marijuana for recreational purposes as early as the spring of 2017.
Financial Post, 12 Oct 2016
http://business.financialpost.com/m...stocks-on-fire-as-dispensaries-raids-continue
Gw
